???global.info.a_carregar???
Identification

Personal identification

Full name
Joaquim António Faria Monteiro

Citation names

  • Monteiro, Joaquim
  • Faria Monteiro, Joaquim
  • Faria Monteiro, J

Author identifiers

Ciência ID
111B-81BC-6CC4
ORCID iD
0000-0002-1635-8811

Email addresses

  • joaquimmonteiro@gmail.com (Professional)
  • joaquim.monteiro@iucs.cespu.pt (Professional)
  • j.monteiro@ff.up.pt (Professional)

Addresses

  • Laboratório Farmacologia, Ed 3, Piso 4, Rua. de Jorge de Viterbo Ferreira 228, 4050-313, Porto, Porto, Portugal (Professional)

Knowledge fields

  • Medical and Health Sciences - Basic Medicine - Pharmacology and pharmacy
  • Medical and Health Sciences - Clinical Medicine
  • Medical and Health Sciences - Clinical Medicine - Other Clinical Medicine Subjects

Languages

Language Speaking Reading Writing Listening Peer-review
Portuguese Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
English Intermediate (B1) Advanced (C1) Intermediate (B1) Intermediate (B1)
Spanish; Castilian Advanced (C1) Advanced (C1) Advanced (C1) Advanced (C1)
French Beginner (A1) Advanced (C1) Beginner (A1) Beginner (A1)
Education
Degree Classification
2019
Concluded
 Medicina (Mestrado)
Major in Sem especialização
Universidade do Porto Faculdade de Medicina, Portugal
"Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations" (THESIS/DISSERTATION)
2016
Concluded
 Licenciatura em Ciências Básicas da Saúde (Licenciatura)
Universidade do Porto Faculdade de Medicina, Portugal
"Sem tese" (THESIS/DISSERTATION)
 13,4
2010
Concluded
 Doutor europeu em Biomedicina e Farmácia (Doctor)
Universitat de València, Spain
"Individualización Posológica de Carboplatino en Pacientes Ancianos con Cáncer de Pulmón no Microcítico Avanzado" (THESIS/DISSERTATION)
 Sobresaliente cum Laude
2007
Concluded
 MASTER EN INVESTIGACIÓN Y DESARROLLO DE MEDICAMENTOS (Master)
Universitat de València, Spain
"MODELO FARMACOCINETICO POBLACIONAL DE CARBOPLATINO EN PACIENTES ANCIANOS CON CANCER DE PULMON NO MICROCITICO AVANZADO (Populational pharmacokinetic model of carboplatin in elderly patients with advanced non-small cell lung cancer)" (THESIS/DISSERTATION)
 10 (0-10 scale)
2006
Concluded
 LICENCIATURA EM CIENCIAS FARMACEUTICAS (Licenciatura)
Universidade do Porto Faculdade de Farmácia, Portugal
 13
Affiliation

Teaching in Higher Education

Category
Host institution 		Employer
2025/03/23 - Current Assistant Professor (University Teacher) Universidade do Porto Faculdade de Farmácia, Portugal
2021/09/01 - 2025/03/22 Invited Assistant (University Teacher) Universidade do Porto Faculdade de Farmácia, Portugal
2013 - 2025/03/22 Assistant Professor (University Teacher) Instituto Universitário de Ciências da Saúde, Portugal
2013 - 2019 Assistant Professor (University Teacher) Instituto Universitário de Ciências da Saúde, Portugal
2013 - 2016 Invited Assistant Professor (University Teacher) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2013 - 2016 Invited Assistant Professor (University Teacher) Universidade do Porto Instituto de Ciências Biomédicas Abel Salazar, Portugal
2014 - 2015 Adjunct Teacher (Polytechnic Teacher) Instituto Politécnico de Saude do Norte Escola Superior de Saúde do Vale do Sousa, Portugal
2014 - 2015 Adjunct Teacher (Polytechnic Teacher) Instituto Politécnico de Saude do Norte - Campus de Penafiel, Portugal

Other Careers

Category
Host institution 		Employer
2020/01/01 - 2022/09/02 Interno (Médica) Centro Hospitalar Universitário de São João, Portugal

Positions / Appointments

Category
Host institution 		Employer
2013 - 2019 Conselho científico/técnico-científico ou orgão correspondente Instituto Universitário de Ciências da Saúde, Portugal
2013 - 2016 Conselho científico/técnico-científico ou orgão correspondente Instituto Universitário de Ciências da Saúde, Portugal
Projects

Grant

Designation Funders
2013/01/01 - 2014/12/01 Development and validation of a pharmacokinetic/pharmacodynamic model to individualize carboplatin and gemcitabine doses for elderly patients with advanced non-small cell lung cancer
PTDC/SAU-FCF/104448/2008
Post-doc Fellow

Contract

Designation Funders
2013/01/01 - 2014/01/01 GALENO - Modeling and Control for personalized drug administration
PTDC/SAU-BEB/103667/2008
Researcher
Concluded
2010/05/01 - 2013/10/31 Desenvolvimento e validação de um modelo farmacocinético/farmacodinâmico para a individualização das doses de carboplatina e gemcitabina a administrar em doentes idosos com carcinoma de pulmão de não pequenas células avançado
PTDC/SAU-FCF/104448/2008
Universidade do Porto Instituto de Ciências e Tecnologias Agrárias e Agro-Alimentares, Portugal

Rede de Química e Tecnologia Laboratório Associado para a Química Verde, Portugal

Instituto Português de Oncologia do Porto Francisco Gentil EPE, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2010/04/01 - 2013/09/30 GALENO - Modelação e controlo para administração personalizada de fármacos
PTDC/SAU-BEB/103667/2008
Universidade de Aveiro Centro de Investigação e Desenvolvimento em Matemática e Aplicações, Portugal

Universidade do Porto Faculdade de Ciências, Portugal

Universidade do Porto Instituto de Ciências e Tecnologias Agrárias e Agro-Alimentares, Portugal

Centro Hospitalar Universitário do Porto EPE, Portugal

Instituto de Engenharia de Sistemas e Computadores Investigação e Desenvolvimento em Lisboa, Portugal

Unidade Local de Saúde de Matosinhos EPE, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
Outputs

Publications

Journal article
  1. Monteiro JM; Monteiro, Joaquim Faria; Damas Rita; Bergantim Rui; Trigo Fernanda. "Optimum Methotrexate Exposure in Patients with Suspected or Confirmed CNS Invasive Hematological Malignancies: A Systematic Critical Review". Therapeutic Drug Monitoring Publish Ah (2022): http://dx.doi.org/10.1097/ftd.0000000000001022.
    10.1097/ftd.0000000000001022
  2. "Glioblastoma Vasculature: From its Critical Role in Tumor Survival to Relevant in Vitro Modelling". Frontiers in Drug Delivery 2 (2022): http://dx.doi.org/10.3389/fddev.2022.823412.
    10.3389/fddev.2022.823412
  3. Joaquim F. Monteiro; Siomara R. Hahn; Jorge Gonçalves; Paula Fresco. "Vancomycin therapeutic drug monitoring and population pharmacokinetic models in special patient subpopulations". Pharmacology Research & Perspectives 6 4 (2018): e00420-e00420. https://doi.org/10.1002/prp2.420.
    10.1002/prp2.420
  4. Campos SP; de Lurdes Pinto M; Gomes G; de Pinho PG; Monteiro JA; Félix LM; Branco PS; Ferreira LM; Antunes LM. "Expression of CYP1A1 and CYP1A2 in the liver and kidney of rabbits after prolonged infusion of propofol.". (2016): http://europepmc.org/abstract/med/27531257.
    10.1016/j.etp.2016.07.006
  5. Campos, S.; Monteiro, J.; Valenzuela, B.; Gonçalinho, H.; de Pinho, P.G.; Fresco, P.; Félix, L.; et al. "Evidence of Different Propofol Pharmacokinetics under Short and Prolonged Infusion Times in Rabbits". Basic and Clinical Pharmacology and Toxicology 118 6 (2016): 421-431. http://www.scopus.com/inward/record.url?eid=2-s2.0-84964735393&partnerID=MN8TOARS.
    10.1111/bcpt.12521
  6. Ribeiro J; Figueiredo P; Sousa A; Monteiro J; Pelarigo J; Vilas-Boas JP; Toussaint HM; Fernandes RF. "VO2 kinetics and metabolic contributions during full and upper body extreme swimming intensity.". (2015): http://europepmc.org/abstract/med/25547736.
    10.1007/s00421-014-3093-5
  7. Silva C; Ramalho C; Luz I; Monteiro J; Fresco P. "Drug-related problems in institutionalized, polymedicated elderly patients: opportunities for pharmacist intervention.". (2015): http://europepmc.org/abstract/med/25637404.
    10.1007/s11096-014-0063-2
  8. Azevedo AR; de Sousa HM; Monteiro JA; Lima AR. "Future perspectives of Smartphone applications for rheumatic diseases self-management.". (2015): http://europepmc.org/abstract/med/25168866.
    10.1007/s00296-014-3117-9
  9. Lima A; Bernardes M; Azevedo R; Monteiro J; Sousa H; Medeiros R; Seabra V. "SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients.". (2014): http://europepmc.org/abstract/med/25124723.
    10.1093/toxsci/kfu162
  10. Lima A; Monteiro J; Bernardes M; Sousa H; Azevedo R; Seabra V; Medeiros R. "Prediction of methotrexate clinical response in Portuguese rheumatoid arthritis patients: implication of MTHFR rs1801133 and ATIC rs4673993 polymorphisms.". (2014): http://europepmc.org/abstract/med/24967362.
    10.1155/2014/368681
  11. Lima A; Sousa H; Monteiro J; Azevedo R; Medeiros R; Seabra V. "Genetic polymorphisms in low-dose methotrexate transporters: current relevance as methotrexate therapeutic outcome biomarkers.". (2014): http://europepmc.org/abstract/med/25340735.
    10.2217/pgs.14.116
  12. Monteiro, Joaquim. "Simultaneous Quantification of Propofol and its Non-Conjugated Metabolites in Several Biological Matrices Using Gas Chromatography/Ion Trap Mass Spectrometry Method". J of Analytical and Bioanalytical Techniques (2014): https://www.omicsonline.org/open-access/quantification-of-propofol-and-its-non-conjugated-metabolites-2155-9872-5-195.php?aid=28332.
    10.4172/2155-9872.1000195
  13. Palmas, R.A.; Monteiro, J.; Fresco, P.. "Analytical methods fortaxanes quantification in diluted formulations and biological samples and their applications in clinical practice". International Journal of Pharmacy and Pharmaceutical Sciences 6 6 (2014): 17-23. http://www.scopus.com/inward/record.url?eid=2-s2.0-84903897530&partnerID=MN8TOARS.
  14. Vidal, H.; Gonçalinho, H.; Monteiro, J.; das Neves, J.; Sarmento, B.; Diniz, C.; Fresco, P.. "Development and validation of a rapid and simple reversed-phase HPLC method for the determination of gemcitabine in human plasma". International Journal of Pharmacy and Pharmaceutical Sciences 6 9 (2014): 59-65. http://www.scopus.com/inward/record.url?eid=2-s2.0-84907853998&partnerID=MN8TOARS.
  15. Silva, Cristina; Fresco, Paula; Monteiro, Joaquim; Rama, Ana Cristina Ribeiro. "Online drug databases: a new method to assess and compare inclusion of clinically relevant information". International Journal of Clinical Pharmacy 35 4 (2013): 560-569. http://dx.doi.org/10.1007/s11096-012-9746-8.
    10.1007/s11096-012-9746-8
  16. Monteiro, Joaquim. "Effect of Age on Systemic Exposure and Haematological Toxicity of Carboplatin in Advanced Non-Small Cell Lung Cancer Patients". (2011):
    10.1111/j.1742-7843.2011.00753.x
  17. Monteiro, Joaquim; Silva, A.; Campos, S.; Monteiro, J.; Vengncio, C.; Costa, B.; Guedes De Pinho, P.; Antunes, L.. "Performance of Anesthetic Depth Indexes in Rabbits under Propofol Anesthesia". Anesthesiology 115 2 (2011): 303-314. http://www.scopus.com/inward/record.url?eid=2-s2.0-79961024408&partnerID=MN8TOARS.
    10.1097/aln.0b013e318222ac02
  18. Torres, N.V.J.; Sanjuán, M.M.; Cubells, D.A.; Monteiro, J.A.; Maiques, I.M.; Arenas, V.J.. "Individual dosing of carboplatin in elderly patients with advanced non small cell lung cancer,Individualización de Carboplatino en el anciano con cáncer de pulmón no microcítico avanzado". Anales de la Real Academia Nacional de Farmacia 73 4 (2007): 1265-1285. http://www.scopus.com/inward/record.url?eid=2-s2.0-49149105940&partnerID=MN8TOARS.
Working paper
  1. Monteiro, Joaquim. 2014. "Development and validation of a rapid and simple reversed-phase HPLC method for the determination of gemcitabine in human plasma". https://innovareacademics.in/journals/index.php/ijpps/article/view/3200/1190.
Activities

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2014 - 2019 Metodologia de individualização posológica de vancomicina e o seu impacto num hospital terciário brasileiro
Co-supervisor
 Programa Doutoral em Ciências Farmacêuticas - Farmacologia (PhD)
Universidade do Porto Faculdade de Farmácia, Portugal
2011 - 2015 Estudo e Aplicação da Modelação Farmacocinética do Propofol na Anestesia Alvo-controlada em Medicina Veterinária
Co-supervisor
 Programa Doutoral em Medicina Veterinária (PhD)
Universidade de Trás-os-Montes e Alto Douro, Portugal
2011 - 2012 Modelo farmacocinético da carboplatina e gemcitabina em doentes idosos com cancro de pulmão de não pequenas células avançado
Supervisor
 Mestrado em Bioengenharia (Master)
Universidade do Porto Faculdade de Engenharia, Portugal

Jury of academic degree

Topic
Role 		Candidate name (Type of degree)
Institution / Organization
2025/05/28 Identifying Determinants and Consequences of Drug-induced Acute Kidney Injury
(Thesis) Arguer
 Catarina da Luz Rodrigues de Oliveira (PhD)
Universidade de Lisboa Faculdade de Farmácia, Portugal
2015/10 Caracterização Bioenergética e Biomecânica em Intensidades Moderada a Severa
(Thesis) Arguer
 Kelly de Jesus (PhD)
Universidade do Porto Faculdade de Desporto, Portugal
2013/01/18 AVALIAÇÃO DA UTILIDADE DE PARÂMETROS CINÉTICOS DERIVADOS DO CA-125 NO ACOMPANHAMENTO DO CANCRO EPITELIAL DO OVÁRIO
(Thesis) Main arguer
 António João Sales Mano (PhD)
Universidade de Coimbra Faculdade de Farmácia, Portugal
2011/10 Electroencephalogram derived indexes for precise control of animal anaesthesia
(Thesis) Main arguer
 Aura Silva (PhD)
Universidade de Trás-os-Montes e Alto Douro, Portugal

Evaluation committee

Activity description
Role 		Institution / Organization Funding entity
2011 - 2015 Comissão de acompanhamento do programa doutoral da Faculdade de Desporto da Universidade do Porto intitulada: Caracterização Bioenergética e Biomecânica em Intensidades Moderada a Severa
Evaluator
 Universidade do Porto Faculdade de Desporto, Portugal
Distinctions

Other distinction

2007 International prize in Máster “Investigación y Uso Racional del medicamento”